Kusuzaki K - Search Results

1

Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma.

Matsumoto Y, Nomura K, Kanda-Akano Y, Fujita Y, Nakao M, Ueda K, Horiike S, Yokota S, Kusuzaki K, Kitoh T, Watanabe A, Taniwaki M. Matsumoto Y, et al. Among authors: kusuzaki k. Leuk Lymphoma. 2003 May;44(5):879-82. doi: 10.1080/1042819031000067873. Leuk Lymphoma. 2003. PMID: 12802930

2

Multiple bone lesions after allogeneic bone marrow transplantation in a patient with relapsed adult acute lymphoblastic leukemia: minimal residual disease analysis may predict extramedullary relapse.

Nomura K, Okamoto T, Nakao M, Ueda K, Akano Y, Fujita Y, Kobayashi M, Yokota S, Horiike S, Nishida K, Kusuzaki K, Taniwaki M. Nomura K, et al. Among authors: kusuzaki k. Leuk Lymphoma. 2001 Nov-Dec;42(6):1305-8. doi: 10.3109/10428190109097756. Leuk Lymphoma. 2001. PMID: 11911412

3

Cell proliferation and differentiation of cultured chondrocytes isolated from growth plate cartilage of rat rib.

Tsuji Y, Takeshita H, Kusuzaki K, Hirasawa Y, Ueda K, Ashihara T. Tsuji Y, et al. Among authors: kusuzaki k. Nihon Geka Hokan. 1995 Mar 1;64(2):50-63. Nihon Geka Hokan. 1995. PMID: 8678724

4

Rapid recurrence of calcifying fibrous pseudotumor (a case report).

Maeda A, Kawabata K, Kusuzaki K. Maeda A, et al. Among authors: kusuzaki k. Anticancer Res. 2002 May-Jun;22(3):1795-7. Anticancer Res. 2002. PMID: 12168871

5

Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma.

Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T, Hirasawa Y. Hashiguchi S, et al. Among authors: kusuzaki k. Oncology. 2002;62(1):85-93. doi: 10.1159/000048251. Oncology. 2002. PMID: 11810048

6

Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model.

Hara K, Kusuzaki K, Takeshita H, Kuzuhara A, Tsuji Y, Ashihara T, Hirasawa Y. Hara K, et al. Among authors: kusuzaki k. Anticancer Res. 2001 Jan-Feb;21(1A):321-4. Anticancer Res. 2001. PMID: 11299756

7

Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line.

Hirata M, Kusuzaki K, Takeshita H, Hashiguchi S, Hirasawa Y, Ashihara T. Hirata M, et al. Among authors: kusuzaki k. Anticancer Res. 2001 Jan-Feb;21(1A):317-20. Anticancer Res. 2001. PMID: 11299755

8

Two cases of secondary angiosarcoma arising from fibrous dysplasia.

Fukuroku J, Kusuzaki K, Murata H, Nakamura S, Takeshita H, Hirata M, Hashiguchi S, Hirasawa Y. Fukuroku J, et al. Among authors: kusuzaki k. Anticancer Res. 1999 Sep-Oct;19(5C):4451-7. Anticancer Res. 1999. PMID: 10650791

9

Acquisition of multidrug resistance in osteosarcomas, analyzed by doxorubicin binding assay, and histologic response to chemotherapy.

Kusuzaki K, Hirata M, Hashiguchi S, Takeshita H, Murata H, Ashihara T, Hirasawa Y. Kusuzaki K, et al. Anticancer Res. 1999 Nov-Dec;19(6B):5159-62. Anticancer Res. 1999. PMID: 10697527

10

DNA ploidy alterations detected during dedifferentiation of periosteal chondrosarcoma.

Murata H, Kusuzaki K, Kuzuhara A, Takeshita H, Nakamura S, Tsuji Y, Hirasawa Y, Ashihara T. Murata H, et al. Among authors: kusuzaki k. Anticancer Res. 1999 May-Jun;19(3B):2285-8. Anticancer Res. 1999. PMID: 10472345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters